Company Filing History:
2 out of 188 
1 out of 846 
1 out of 1 Years Active: 1986-2010
Title: Tetsuya Tachikawa: Innovator in Adiponectin Analysis and Antibody Assays
Introduction
Tetsuya Tachikawa is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of biomedical analysis, particularly in the development of reagents and methods for analyzing adiponectin and antibodies. With a total of 4 patents to his name, Tachikawa's work has the potential to enhance diagnostic accuracy and efficiency in medical settings.
Latest Patents
Tachikawa's latest patents include a latex reagent for adiponectin analysis and a method for adiponectin analysis. The latex reagent comprises a suspension of latex particles that carry a substance specifically binding to adiponectin. This innovative method allows for the analysis of adiponectin without the need for predilution or pretreatment of the biological liquid, making the process rapid and convenient.
Another significant patent involves a method for the assay of antibodies and an antibody assay device. This technology enables high accuracy and specificity in detecting antibodies directed to sources of infection in body fluids. The method utilizes a reagent with specific affinity for the Fc region of an antibody IgG, enhancing the reliability of the assay results.
Career Highlights
Throughout his career, Tachikawa has worked with prominent companies such as Otsuka Pharmaceutical Factory, Inc. and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has contributed to his expertise in the field of biomedical innovations.
Collaborations
Tachikawa has collaborated with notable colleagues, including Fumio Shimizu and Nobuhiro Ikei. These partnerships have likely fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tetsuya Tachikawa's contributions to the field of biomedical analysis through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in diagnostic methods and technologies.